| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2bcf662c80552fd6d66675860e15534f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_def49f1286a839076f43fba94e3bc723
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e9e250a939772e4fec7713d0ef273c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc408585f6863d7865c90ab9a4632135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b348e83f766adba4711608b3b030f20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0053749386a773dbc1733df7404e34e8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4468 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 |
| filingDate |
2010-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3874c744cb8b1cefdbd7b80e57950851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9eb5f44d2c49f3df88a464291b43c27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_931dc19979620547a16e64e060ce0391
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb047845c41ad2bd4d04c77ca1abf4bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48e80b0a7712eb64f4c7ff32b34d02f9 |
| publicationDate |
2010-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010141824-A2 |
| titleOfInvention |
Use of targeted nitroxide agents in bone healing |
| abstract |
Provided herein are compositions and related methods useful for accelerating bone healing and growth. The compounds comprise a nitroxide-containing group attached to a mitochondria-targeting group. The compounds can be cross-linked into dimers without loss of activity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012112851-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106866784-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9732105-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012112851-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9217000-B2 |
| priorityDate |
2009-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |